Literature DB >> 26140885

HIDA Scan with Ejection Fraction Is over Utilized in the Management of Biliary Dyskinesia.

Amanda H Eckenrode1, Joseph A Ewing, Jennifer Kotrady, Allyson L Hale, Dane E Smith.   

Abstract

Patients with upper abdominal pain, nausea, and vomiting are often evaluated with ultrasound to diagnose symptomatic cholelithiasis or cholecystitis. With a normal ultrasound, a hepatobiliary iminodiacetic acid (HIDA) scan with ejection fraction (EF) is recommended to evaluate gallbladder function. The purpose of this study was to evaluate whether the HIDA scan with EF was appropriately utilized in considering cholecystectomy. Over 18 months, we performed 1533 HIDA scans with EF. After exclusion, 1501 were analyzable, 438 of whom underwent laparoscopic cholecystectomy. Patients were divided into two groups: those with typical and atypical symptoms of biliary colic. Our primary endpoint was symptom resolution of those who underwent laparoscopic cholecystectomy. Symptom resolution was assessed by chart review of postop visits or readmissions. In patients with typical symptoms, resolution occurred in 66 per cent of patients with positive HIDA and 77 per cent with negative HIDA (P = 0.292). In patients with atypical symptoms, resolution occurred in 64 per cent of patients with positive HIDA and 43 per cent with negative HIDA (P = 0.013). A HIDA scan with EF was not useful in patients with typical symptoms of biliary colic and negative ultrasounds, and should not be used to make a decision for cholecystectomy. However, this test can be helpful in patients with atypical symptoms, as it does predict symptom improvement in this group.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26140885

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  1 in total

1.  Improving Hepatobiliary Imaging as a Physiologic Test with Superior Clinical Outcomes.

Authors:  Isis W Gayed; Lydia Dawood; Zhang Xu; Grace Rizk; Andrew Dupont; Monica Atta; Emily K Robinson
Journal:  World J Nucl Med       Date:  2020-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.